Head-to-head dispatch
Pallas Health vs Vytora Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Pallas Health names all six of the pharmacies that dispense for it and two prescribing clinicians whose NPIs verify in the federal registry — then sells every GLP-1 on a single twelve-week prepay, so the advertised “/mo average” is one $597 or $897 charge divided by three.
Marked down on: There is no month-to-month rung for either compounded molecule — the funnel renders no cadence selector — so the advertised “$199/mo average” is a single $597 charge every twelve weeks divided by three
Desk Score
Low flat pricing on both molecules with brand access and full nationwide reach — value without the state limits.
Marked down on: Injectable only — no oral route
Vytora Health takes this head-to-head with the higher Desk Score, 90/100 (A−) against 87/100 (B+) for Pallas Health. Pallas Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Pallas Health
87/100
B+
Vytora Health
90/100
A−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Pallas Health | Vytora Health |
|---|---|---|
| Semaglutide | $199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold) | $150/mo |
| Tirzepatide | $299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold) | $200/mo |
| Coverage | All 50 states + DC (async in 43; 7 states plus DC require one video visit) | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one. | Budget-minded patients who want brand access and all-50-state coverage in one place. |
| Desk Score | 87/100B+ | 90/100A− |
The verdict
Desk pick — Vytora HealthVytora Health takes this head-to-head with the higher Desk Score, 90/100 (A−) against 87/100 (B+) for Pallas Health. Pallas Health still holds its ground where its strengths line up with yours.
Choose Pallas Health if…
Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.
$199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold) sema · $299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold) tirz · All 50 states + DC (async in 43; 7 states plus DC require one video visit)
Choose Vytora Health if…
Budget-minded patients who want brand access and all-50-state coverage in one place.
$150/mo sema · $200/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Pallas Health · Vytora Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Pallas Health vs CoreAge Rx
- Vytora Health vs Vaylen
- Pallas Health vs Strut Health
- Vytora Health vs Ondra Health
- Pallas Health vs Invigor Medical
- Vytora Health vs Sesame Care
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.